These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15112620)

  • 1. Absence of transmission of the D9 measles virus in the region of the Americas, November 2002 - May 2003.
    Epidemiol Bull; 2003 Mar; 24(1):24. PubMed ID: 15112620
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of transmission of the d9 measles virus--Region of the Americas, November 2002-March 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(11):228-9. PubMed ID: 12665116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward measles eradication in the region of the Americas.
    De Quadros CA; Izurieta H; Carrasco P; Brana M; Tambini G
    J Infect Dis; 2003 May; 187 Suppl 1():S102-10. PubMed ID: 12721900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the Centers for Disease Control and Prevention. Public health dispatch: absence of transmission of the d9 measles virus--region of the Americas, November 2002-March 2003.
    JAMA; 2003 Apr 23-30; 289(16):2063. PubMed ID: 12709452
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress toward measles elimination--region of the Americas, 2002-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(14):304-6. PubMed ID: 15085074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measles].
    Gasnier JL
    Soins; 1979 May; 24(10):3-9. PubMed ID: 256636
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of specific prophylaxis against measles].
    Andzhaparidze OG; Gordienko HM; Sokolova TM; Dorofeev VM
    Vestn Akad Med Nauk SSSR; 1975; (4):27-33. PubMed ID: 1220365
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility of global measles eradication after interruption of transmission in the Americas.
    de Quadros CA; Andrus JK; Danovaro-Holliday MC; Castillo-Solórzano C
    Expert Rev Vaccines; 2008 Apr; 7(3):355-62. PubMed ID: 18393605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International importation of measles virus--United States, 1993-2001.
    Vukshich Oster N; Harpaz R; Redd SB; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S48-53. PubMed ID: 15106089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress towards interrupting indigenous measles transmission, WHO Region of the Americas.
    Wkly Epidemiol Rec; 2002 Jan; 77(3):21-4. PubMed ID: 11822089
    [No Abstract]   [Full Text] [Related]  

  • 11. From the Centers of Disease Control and Prevention. Progress toward interrupting indigenous measles transmission--region of the Americas, January-November 2001.
    JAMA; 2002 Feb; 287(6):709-10. PubMed ID: 11855385
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mass vaccination against measles in Chile with Enders attenuated virus vaccine].
    Ristori C; Boccardo H; Borgoño JM; Miranda M
    Bol Oficina Sanit Panam; 1966 May; 60(5):396-400. PubMed ID: 4222614
    [No Abstract]   [Full Text] [Related]  

  • 13. [Apropos of measles vaccination. Results of the first trials of antimeasles vaccination in France with hyperattenuated living virus vaccine].
    Mande R; Jammet ML; Celers J; Boué A
    Ann Pediatr (Paris); 1967 Jan; 14(1):66-73. PubMed ID: 5597350
    [No Abstract]   [Full Text] [Related]  

  • 14. Measles immunization: ignorance or apathy?
    Honig FM
    Aust J Adv Nurs; 1986; 3(2):4-12. PubMed ID: 3636152
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiologic and clinical results of measles immunization in the district Karl-Marx-city].
    Hajduk F; Hempel HC
    Dtsch Gesundheitsw; 1968 Dec; 23(52):2483-9. PubMed ID: 5715950
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress toward interrupting indigenous measles transmission--Region of the Americas, January 1999-September 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(43):986-90. PubMed ID: 11098862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles vaccination in HIV-infected children.
    Rose VL; Preboth M
    Am Fam Physician; 1999 Nov; 60(7):2179. PubMed ID: 10569516
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress toward measles elimination--region of the Americas, 2002-2003.
    Ann Pharmacother; 2004 Jun; 38(6):1108. PubMed ID: 15122007
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of a large-scale field trial with the measles vaccine "L-16 SSW"].
    Seyfert PH; Starke G; Hantsch H
    Dtsch Gesundheitsw; 1967 Nov; 22(47):2243-4. PubMed ID: 5593997
    [No Abstract]   [Full Text] [Related]  

  • 20. Measles: a continuing saga.
    Armstrong H; Foster SL
    J Am Pharm Assoc (2003); 2012; 52(3):414-6. PubMed ID: 22618983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.